Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02023242 · ClinicalTrials.gov registry record · NA
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
A NA study of Primary Open Angle Glaucoma and Pigmentary Glaucoma, sponsored by Ivantis.
- Completed
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 1
- Study location
NCT02023242 is a NA study of Primary Open Angle Glaucoma and Pigmentary Glaucoma that has completed, run by Ivantis. The registered enrollment target is 152 participants, below the 286-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02023242, a NA study of Primary Open Angle Glaucoma and Pigmentary Glaucoma, has completed, sponsored by Ivantis.
- COMPLETED
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.
Conditions Studied
Interventions
- DEVICE Hydrus Microstent
- DEVICE iStent Trabecular Micro Bypass
Study Locations (1)
California
- Contact Richard Hope at Ivantis - Irvine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2012-10 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02023242
The ClinicalTrials.gov registry entry for NCT02023242 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 19 other Primary Open Angle Glaucoma trials with a reported enrollment target (47% lower). The listed sponsor is Ivantis, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Primary Open Angle Glaucoma appearing as the primary indexed condition, and to 2 interventions - of which Hydrus Microstent is the first listed.
NCT02023242 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02023242 about?
NCT02023242 is a clinical study titled "Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes". This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.
What is the current status of trial NCT02023242?
This trial is currently completed. It is a NA study. The enrollment target is 152 participants. The study started on 2012-10. Estimated completion is 2018-01.
What conditions does trial NCT02023242 study?
This clinical trial studies the following conditions: Primary Open Angle Glaucoma, Pigmentary Glaucoma, Pseudoexfoliative Glaucoma.
What interventions are being tested in trial NCT02023242?
The interventions under investigation include: Hydrus Microstent (DEVICE), iStent Trabecular Micro Bypass (DEVICE).
Who is sponsoring clinical trial NCT02023242?
This trial is sponsored by Ivantis, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02023242 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Primary Open Angle Glaucoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hydrus® Microstent New Enrollment Post-Approval Study
RECRUITING · NA
-
Safety and Effectiveness of Minimally Invasive Micro Sclerostomy (MIMS®) to Reduce Intraocular Pressure in Open-Angle Glaucoma Which is Not Controlled Despite Polypharmacy
RECRUITING · NA
-
Cataract Surgery in Conjunction With Ab-interno Canaloplasty Compared to Cataract Surgery Only in Patients With Mild to Moderate Primary Open-Angle Glaucoma
RECRUITING · NA
-
Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial
RECRUITING · NA
-
The Effects of Visior on Ocular Hemodynamics
COMPLETED · NA
-
A Study of AMDX-2011P in Participants With Primary Open Angle Glaucoma
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.